Azacitidine Improves Outcome in High Risk MDS Patients with Chromosome 7 Abnormalities: Retrospective Comparison of GESMD and GFM Registries. (April 2017) - Díez Campelo, M.E.; Lorenzo, J.I.; Itzykson, R.; Rojas, S.M.; Berthon, C.; Pérez-Oteiza, J.; Beyne-Rauzy, O.; Bargay, J.; Vey, N.; Cedena, T.; Park, S.; Such, E.; et al.